<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Role of viruses in wheezing and asthma: An overview
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Role of viruses in wheezing and asthma: An overview
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Role of viruses in wheezing and asthma: An overview
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Gregory Redding, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert A Wood, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth TePas, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 04, 2021.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Viral respiratory tract infections are the most common cause of wheezing illnesses and asthma exacerbations in both children and adults [
         <a href="#rid1">
          1-4
         </a>
         ]. In young children, infection with viral respiratory infections can induce symptoms of acute bronchiolitis, croup, and recurrent wheezing. Wheezing with viral infections, particularly respiratory syncytial virus (RSV) and human rhinovirus (RV), may predispose infants and young children to develop asthma later in life [
         <a href="#rid5">
          5-11
         </a>
         ]. RV and RSV are the most common viruses detected in wheezing illnesses and asthma exacerbations, although multiple viruses including enteroviruses, bocaviruses, coronaviruses, parainfluenza, influenza, human metapneumoviruses (hMPV), and adenoviruses can trigger acute exacerbations in both children and adults with asthma  (
         <a class="graphic graphic_table graphicRef75402" href="/z/d/graphic/75402.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
         The mechanisms by which viral respiratory infections trigger wheezing and asthma exacerbations are reviewed here. The influence of viral infection on both the development and perpetuation of asthma is also discussed. Other issues relating to the pathogenesis of asthma are reviewed elsewhere. Treatment of virus-induced wheezing and asthma is also discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/522.html" rel="external">
          "Pathogenesis of asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/572.html" rel="external">
          "Risk factors for asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/567.html" rel="external">
          "Natural history of asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/546.html" rel="external">
          "Treatment of recurrent virus-induced wheezing in young children"
         </a>
         .)
        </p>
        <p>
         The differential diagnosis of wheezing in children includes a variety of congenital and acquired conditions  (
         <a class="graphic graphic_table graphicRef67370" href="/z/d/graphic/67370.html" rel="external">
          table 2
         </a>
         ). Other conditions that involve a variety of anatomic airway locations can produce obstruction and expiratory or inspiratory wheezing in adults. The evaluation of patients with wheezing is reviewed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5752.html" rel="external">
          "Evaluation of wheezing in infants and children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/563.html" rel="external">
          "Evaluation of wheezing illnesses other than asthma in adults"
         </a>
         .)
        </p>
        <p>
         Control of environmental triggers of asthma, risk factors for asthma, and the genetics of asthma are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/562.html" rel="external">
          "Trigger control to enhance asthma management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/572.html" rel="external">
          "Risk factors for asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/561.html" rel="external">
          "Genetics of asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/522.html" rel="external">
          "Pathogenesis of asthma"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H150338024">
         <span class="h1">
          ROLE OF VIRUSES IN WHEEZING IN INFANTS AND YOUNG CHILDREN
         </span>
         <span class="headingEndMark">
          —
         </span>
         Viruses are a common trigger of wheezing illness in children, and virus-induced wheezing represents a heterogeneous group of illnesses including bronchiolitis, asthma exacerbations, and croup. Bronchiolitis, or inflammation of the bronchioles, is a clinical syndrome characterized by wheezing, tachypnea, and hyperinflation of the lungs [
         <a href="#rid13">
          13
         </a>
         ]. It is of primary importance in infants and young children less than two years of age. A first episode of wheezing in association with a viral respiratory infection leads to an outpatient visit for approximately 15 percent of all infants in the United States, and 3 percent are hospitalized with this presentation [
         <a href="#rid14">
          14,15
         </a>
         ]. Bronchiolitis is covered in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6018.html" rel="external">
          "Bronchiolitis in infants and children: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6020.html" rel="external">
          "Bronchiolitis in infants and children: Treatment, outcome, and prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1574855982">
         <span class="h2">
          Specific viruses
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of respiratory viruses are known to cause acute wheezing illnesses in children less than two years of age. These are covered briefly here and reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/6018.html" rel="external">
          "Bronchiolitis in infants and children: Clinical features and diagnosis", section on 'Viral etiology'
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and wheezing in this age group, with most infections occurring in winter and spring months. One study examining the causative factors for acute wheezing in infants and children presenting to the emergency department (ED) found that RSV was the most common infectious agent found in children less than two years of age [
         <a href="#rid16">
          16
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5994.html" rel="external">
          "Respiratory syncytial virus infection: Clinical features and diagnosis in infants and children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Human metapneumovirus (hMPV), a member of the Paramyxoviridae family, is a frequent cause upper and lower respiratory tract infection in infants and children [
         <a href="#rid17">
          17
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8311.html" rel="external">
          "Human metapneumovirus infections", section on 'Children'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rhinovirus (RV) is also a common cause of wheezing and bronchiolitis in infancy [
         <a href="#rid18">
          18
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5978.html" rel="external">
          "The common cold in children: Clinical features and diagnosis", section on 'Virology'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8335.html" rel="external">
          "Epidemiology, clinical manifestations, and pathogenesis of rhinovirus infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Coronaviruses, enterovirus, adenoviruses, bocaviruses, parainfluenza, and influenza can also provoke wheezing in this age group, as well as in older children and adults [
         <a href="#rid19">
          19-23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/8298.html" rel="external">
          "Coronaviruses"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8339.html" rel="external">
          "Pathogenesis, epidemiology, and clinical manifestations of adenovirus infection"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5975.html" rel="external">
          "Parainfluenza viruses in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5973.html" rel="external">
          "Seasonal influenza in children: Clinical features and diagnosis", section on 'Clinical features'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3267020188">
         <span class="h2">
          Risk factors for acute wheezing
         </span>
         <span class="headingEndMark">
          —
         </span>
         The two major risk factors for acute wheezing with viral infection during the first two years of life include exposure to cigarette smoke, particularly maternal smoking, and persistently reduced lung function [
         <a href="#rid24">
          24-29
         </a>
         ]. In predisposed children, postnatal exposures, such as allergic sensitizations and virus-induced wheezing illnesses, may further influence the future development of asthma [
         <a href="#rid5">
          5,10,11,26,30-33
         </a>
         ].
        </p>
        <p>
         The data can be summarized as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A prospective analysis of 1246 children assessing the relationship between initial lung function and the development of a wheezing illness during the first year of life reported that infants with reduced lung function were more likely to develop asthma in childhood. These data are further supported by studies showing that children with prematurity and lower lung function in infancy are at increased risk of RSV-induced lower respiratory illness, recurrent virus-induced wheezing, and asthma [
         <a href="#rid24">
          24,25,27,34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The Copenhagen Prospective Studies on Asthma in Childhood conducted a prospective trial 411 children at risk for the development of asthma and followed lung function with spirometry and
         <a class="drug drug_general" data-topicid="9622" href="/z/d/drug information/9622.html" rel="external">
          methacholine
         </a>
         bronchoprovocation tests as neonates and compared with spirometry conducted in children at age seven years. In this study, children who developed asthma at age seven years had reduced lung function and increased bronchial reactivity as neonates, which then progressed during childhood, with children at age seven years showing progression of the airflow deficits. These findings suggest that children who develop asthma not only exhibit reduced lung function at birth but that wheezing illnesses may worsen lung function in these children [
         <a href="#rid29">
          29
         </a>
         ]. In addition, responses to bacterial and viral pathogens during infancy may further modulate future asthma risk [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Data from the Perth Infant Asthma Follow-up Study showed that bronchial hyperreactivity to histamine during infancy and maternal smoking were associated with an increased risk of wheezing in childhood. However, in subsequent studies, investigators reported that these effects may diminish over time and that postnatal exposures within the environment, such as allergic sensitization and viral infections, play a greater role in lung function and the development of asthma in later childhood and adult life. These findings suggest that a critical window may exist where future asthma risk in predisposed children may be mitigated with interventions that preserve lung function in infancy and early childhood [
         <a href="#rid32">
          32,33
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3887122450">
         <span class="h2">
          Risk factors for recurrent wheezing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Risk factors associated with recurrent wheezing in children aged 12 to 15 months in a cross-sectional study included parental history of asthma, maternal smoking during pregnancy, patient history of bronchopneumonia, daycare attendance, and early exposure to pets [
         <a href="#rid36">
          36
         </a>
         ]. Children over two years of age with wheezing episodes triggered by viral infection are more likely than those without virus-induced wheezing to have features that are associated with a predisposition to asthma including elevated plasma immunoglobulin E (IgE) levels, sensitization to inhalant allergens, eosinophilic inflammation, and maternal history of asthma [
         <a href="#rid16">
          16,37-39
         </a>
         ].
        </p>
        <p>
         In addition, the Tucson Children's Respiratory Study described different phenotypes for children who wheeze in early childhood. These phenotypes include the "transient early" phenotype where children primarily wheeze with viral illnesses, with symptoms often resolving by age six years. Children with the "persistent wheezing" and "late-onset wheezing" phenotypes are associated with a higher risk of allergic sensitization and the subsequent development of asthma [
         <a href="#rid25">
          25
         </a>
         ]. Subsequent birth cohort studies have further established the link between recurrent wheezing with viral illnesses, allergic sensitization, and future asthma risk [
         <a href="#rid5">
          5,9,40
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13585.html" rel="external">
          "Wheezing phenotypes and prediction of asthma in young children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          ROLE OF VIRUSES IN ASTHMA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Viral respiratory infections infect airway epithelium and interact with host factors to promote an inflammatory response that can trigger wheezing illnesses [
         <a href="#rid5">
          5,10,40,41
         </a>
         ]. In susceptible individuals, the virus-induced immune response may mediate host responses to other microbes, infections, allergens, stress, and pollutants, resulting in wheezing and asthma exacerbations.
        </p>
        <p class="headingAnchor" id="H2089501443">
         <span class="h2">
          Host factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although patients with asthma may not be more susceptible to contracting viral illnesses compared with healthy controls, they do suffer a longer duration of symptoms and experience a more severe viral-induced respiratory illness [
         <a href="#rid42">
          42
         </a>
         ]. Host factors likely play a role in this exaggerated immune response to viral infections in patients with asthma.
        </p>
        <p>
         Respiratory viruses, such as influenza and respiratory syncytial virus (RSV), infect and cause cytopathic damage to airway epithelium, which in turn induces the release of proinflammatory cytokine and chemokines such as thymic stromal lymphopoietin (TSLP), interleukin (IL) 25, and IL-33. In turn, this proinflammatory response propagates eosinophilia and stimulates the release of cytokines that promote asthma and atopic disease (IL-4, IL-5, IL-13) [
         <a href="#rid43">
          43-46
         </a>
         ]. Other viruses, such as rhinovirus (RV), may not damage the epithelium directly but rather interact with macrophages, T cells, or mast cells to stimulate allergic airway inflammation and modulate the host response to allergens, irritants, and the environment [
         <a href="#rid43">
          43-46
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3350818645">
         <span class="h2">
          Viral factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Respiratory viral infection and replication activate innate and adaptive antiviral immune responses, resulting in proinflammatory cytokine and chemokine production and the recruitment of inflammatory cells to the airway. Many viruses, including RV, RSV, influenza, coronavirus, human metapneumovirus (hMPV), parainfluenza, adenovirus, and human bocavirus, can trigger wheezing and exacerbations in patients with asthma  (
         <a class="graphic graphic_table graphicRef75402" href="/z/d/graphic/75402.html" rel="external">
          table 1
         </a>
         ). In infants and younger children, wheezing with RSV and RV infection may induce an inflammatory response in a predisposed host that influences the later development of asthma [
         <a href="#rid5">
          5-7,9-11,41,47
         </a>
         ]. (See
         <a class="local">
          'Development of asthma'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3863842882">
         <span class="h2">
          Viruses and the microbiome
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies have suggested that the interaction between viruses and bacteria may increase the risk of wheezing and symptoms of asthma [
         <a href="#rid35">
          35,48
         </a>
         ]. RV infection has been shown to alter the airway microbiome, with increased detection of
         <em>
          Streptococcus pneumoniae
         </em>
         ,
         <em>
          Moraxella catarrhalis
         </em>
         , and
         <em>
          Haemophilus influenzae
         </em>
         in children with and without asthma [
         <a href="#rid49">
          49,50
         </a>
         ]. This coalescing of antimicrobial immune responses was associated with increased respiratory symptoms.
        </p>
        <p class="headingAnchor" id="H3629101439">
         <span class="h2">
          Development of asthma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Viral respiratory tract infections in infancy, particularly with RSV and human RV, are predictive of the development of asthma in later childhood to young adulthood [
         <a href="#rid5">
          5-8,40,41,51-56
         </a>
         ]. Factors including the timing of birth and the subsequent exposure to peak bronchiolitis and viral seasons for RSV and potentially hMPV may influence the future development of asthma in a predisposed host [
         <a href="#rid57">
          57,58
         </a>
         ]. However, it remains unclear whether certain viral respiratory infections cause asthma or if wheezing with viral infections in general are predictors for the subsequent development of asthma [
         <a href="#rid59">
          59
         </a>
         ]. (See
         <a class="local">
          'Role of viruses in asthma'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/572.html" rel="external">
          "Risk factors for asthma", section on 'Respiratory infections'
         </a>
         .)
        </p>
        <p>
         Specific viruses associated with the development of asthma include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Respiratory syncytial virus –
         </strong>
         RSV is a frequent cause of wheezing and bronchiolitis in infants and young children. RSV is a single-stranded enveloped RNA virus separated into two antigenic subgroups, A and B. Subtype A is associated with more virulent illness. RSV binds to airway epithelial cells and then replicates, damaging the airway epithelium and inducing the production of proinflammatory cytokines and chemokines, resulting in the recruitment of granulocytes, monocytes, and dendritic cells. The resulting cytopathic injury to the airway epithelium and airway inflammation causes acute respiratory illness, including acute bronchiolitis and wheezing, particularly in children younger than two years  (
         <a class="graphic graphic_figure graphicRef79253" href="/z/d/graphic/79253.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid30">
          30,60-66
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The causal effect of early-life RSV infections on the subsequent development of asthma is unclear. Observational studies have clearly demonstrated that RSV infections early in life are associated with an increased risk of developing asthma [
         <a href="#rid6">
          6,7,67-69
         </a>
         ]. However, children that have persistent symptoms of asthma or that develop asthma after RSV infection also have asthma risk factors, such as a maternal history of asthma and elevated IgE levels [
         <a href="#rid13">
          13,24,25,37,70-75
         </a>
         ]. In addition, studies investigating whether
         <a class="drug drug_general" data-topicid="9849" href="/z/d/drug information/9849.html" rel="external">
          palivizumab
         </a>
         , a monoclonal antibody directed against RSV antigens, prevents the development of recurrent wheeze have yielded mixed results [
         <a href="#rid69">
          69,76,77
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In findings from a prospective cohort study of premature infants, 146 treated with
         <a class="drug drug_general" data-topicid="9849" href="/z/d/drug information/9849.html" rel="external">
          palivizumab
         </a>
         and 171 untreated, RSV prophylaxis decreased the risk of recurrent wheezing in children without a family history of atopy but had no effect in children from atopic families [
         <a href="#rid69">
          69
         </a>
         ]. The data suggest that prevention of RSV infection is an important factor if you are not at risk for atopy but that family history of atopy overrides any influence of RSV prophylaxis when it comes to the risk of developing asthma (ie, prevention of RSV infection is a dependent variable of atopic predisposition).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In a randomized trial of 429 high-risk infants, treatment of otherwise healthy preterm infants with
         <a class="drug drug_general" data-topicid="9849" href="/z/d/drug information/9849.html" rel="external">
          palivizumab
         </a>
         to prevent severe RSV infection was associated with a decreased rate of recurrent wheeze compared with the placebo group (11 versus 21 percent, respectively) [
         <a href="#rid76">
          76
         </a>
         ]. However, a published six-year follow-up of this trial reported that there was no difference between the groups in physician-diagnosed current asthma or lung function [
         <a href="#rid77">
          77
         </a>
         ]. This follow-up trial suggests that further long-term studies are needed to determine if RSV interacts with specific host factors to induce the development of asthma.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Rhinovirus –
         </strong>
         RV refers to a genetically diverse species of nonenveloped, positive-stranded RNA viruses that are grouped into RV-A, RV-B, and RV-C serotypes [
         <a href="#rid78">
          78
         </a>
         ]. RV, in contrast to RSV and other respiratory viruses, has few cytopathic effects on airway epithelium or other tissues but does induce a significant airway inflammatory immune response and, in patients with asthma, may impair the antiviral interferon (IFN) response during infections with RV.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Wheezing in the setting of RV infection may influence the development of asthma [
         <a href="#rid5">
          5,13,51
         </a>
         ]. Studies have shown that infants who wheeze with RV infection have increased risk of recurrent wheeze and asthma at ages three, five, and six years [
         <a href="#rid9">
          9,40,52
         </a>
         ]. Findings from a high-risk birth cohort, the Childhood Origins of Asthma Study (COAST), have shown that wheezing with RV infection during the first three years of life was a much stronger risk factor for asthma at six years of age than wheezing with RSV infection or the presence of aeroallergen sensitization [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Several studies have shown that RV interacts with host factors, particularly in atopic children, to influence the development of asthma:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Studies suggest that allergic sensitization in the first year of life is the initial event that interacts with viral infections, particularly RV, to promote the development of asthma in children [
         <a href="#rid5">
          5,9,10,31,51,79
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/572.html" rel="external">
          "Risk factors for asthma"
         </a>
         ). Several studies implicate plasmacytoid airway mucosa dendritic cells as the antigen-presenting cell that mediates this synergistic inflammation induced by the presence of atopy and viral infections [
         <a href="#rid80">
          80-82
         </a>
         ]. Specifically, upregulation and crosslinking of the Fc epsilon receptor that binds IgE on lung dendritic cells may promote T helper cell type 2 (Th2) inflammation and modulate type I and type III IFN antiviral responses  (
         <a class="graphic graphic_figure graphicRef82258" href="/z/d/graphic/82258.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid80">
          80-87
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         These findings are further supported by clinical studies in urban children with asthma showing that
         <a class="drug drug_general" data-topicid="10251" href="/z/d/drug information/10251.html" rel="external">
          omalizumab
         </a>
         , an anti-IgE monoclonal antibody, decreases the duration of RV infection and the frequency of RV illnesses [
         <a href="#rid88">
          88
         </a>
         ]. Mechanistically, omalizumab was shown to increase IFN-alpha from RV stimulated peripheral blood mononuclear cells, which was associated with fewer asthma exacerbations [
         <a href="#rid89">
          89
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Genotypic variants at the 17q21 locus are associated with both RV wheezing illnesses in early childhood and the development of asthma in these children [
         <a href="#rid90">
          90
         </a>
         ]. Strong interactions with respect to subsequent risk of asthma were demonstrated between 17q21 genotypes and RV-induced wheezing. In addition, variants in the gene encoding cadherin-related family member 3 (CDHR3) may be linked to increasing wheezing illnesses in children by mediating increased RV-C entry into host cells [
         <a href="#rid78">
          78,91
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/561.html" rel="external">
          "Genetics of asthma"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/572.html" rel="external">
          "Risk factors for asthma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Human metapneumovirus (hMPV)
         </strong>
         – hMPV is an RNA paramyxovirus with phylogenetic similarity to RSV. hMPV is a frequent cause of acute respiratory illness in children and adults, accounting for approximately 5 percent of acute respiratory illnesses in hospitalized children [
         <a href="#rid19">
          19
         </a>
         ]. The virus typically peaks between December and April in the Northern Hemisphere and January to May in the Southern Hemisphere. The severity of illness is often greater in premature infants. The following studies are illustrative:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Surveillance data have shown that hMPV detection in hospitalized children younger than five years of age is associated with an increased risk of intensive care unit (ICU) stays and need for supplemental oxygen during hospitalization [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Retrospective data suggest that young children hospitalized with hMPV lower respiratory tract infections have an increased risk of developing asthma at age five years [
         <a href="#rid17">
          17
         </a>
         ]. This increased risk of asthma development was similar to RSV-associated risk in this small study.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prospective data for one small study suggest that hMPV is associated with a higher risk of recurrent wheezing and potentially subsequent asthma diagnoses, although an increased risk of asthma development at age six years was not established [
         <a href="#rid93">
          93
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Influenza –
         </strong>
         Children and adults with asthma are at an increased risk of hospitalizations and respiratory morbidity during acute influenza respiratory infections [
         <a href="#rid94">
          94,95
         </a>
         ]. Children with asthma were particularly prone to increased ICU stays and pneumonia during the 2009 to 2010 H1N1 pandemic. Influenza, along with RSV and parainfluenza, is also associated with a higher risk of emergency department (ED) treatment failure for acute respiratory illness (c) [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
         </strong>
         – Asthma does not appear to be a strong risk factor for acquiring coronavirus disease 2019 (COVID-19; SARS-CoV-2) or to increase the risk of more severe disease or death for the majority of patients [
         <a href="#rid96">
          96-99
         </a>
         ]. Neither the use of inhaled glucocorticoids nor the diagnosis of asthma conferred an increased risk of hospitalization in a large, single-center, electronic health records-based study of a mostly adult population [
         <a href="#rid100">
          100
         </a>
         ]. Patients hospitalized with COVID-19 infection and a history of asthma do not suffer an increased rate of SARS-CoV-2 pneumonia, acute respiratory distress syndrome (ARDS), or death, although one US case series reported a link between asthma and prolonged intubation time in adults aged 18 to 65 years with asthma who were hospitalized with COVID-19 [
         <a href="#rid101">
          101,102
         </a>
         ]. Molecular analyses have shown that two airway epithelial proteins that are in part modulated by asthma and allergic disease (angiotensin-converting enzyme 2 [ACE2] and the transmembrane protease serine 2 [TMPRSS2]) also mediate cell entry of the SARS-CoV-2 virus. Preliminary studies suggested that some patients with asthma may express lower levels of ACE2 in airway epithelium [
         <a href="#rid103">
          103-105
         </a>
         ]. However, the regulation of ACE2 and TMPRSS2 is poorly understood and known to be mediated by other chronic diseases. Further study is needed to determine the role of these proteins in SARS-COV-2 infection. (See
         <a class="medical medical_review" href="/z/d/html/547.html" rel="external">
          "An overview of asthma management", section on 'Advice related to COVID-19 pandemic'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additional information about COVID-19 is provided separately. (See
         <a class="medical medical_review" href="/z/d/html/129849.html" rel="external">
          "COVID-19: Vaccines"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/128389.html" rel="external">
          "COVID-19: Management in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127759.html" rel="external">
          "COVID-19: Evaluation of adults with acute illness in the outpatient setting"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/127429.html" rel="external">
          "COVID-19: Management in hospitalized adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Asthma exacerbations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Viral respiratory infections are an important cause of increased pulmonary symptoms in children and adults with preexisting asthma [
         <a href="#rid13">
          13,38,39,51,106-108
         </a>
         ]. Studies have shown that viral infections trigger up to 85 percent of asthma exacerbations in school-aged children and up to 50 percent of exacerbations in adults [
         <a href="#rid109">
          109,110
         </a>
         ]. RV is the predominant pathogen identified in school-aged children and adult patients with acute asthma exacerbations [
         <a href="#rid5">
          5,9,40,51,52
         </a>
         ]. Infection with RV-C is associated with more severe disease in children admitted for asthma exacerbations [
         <a href="#rid111">
          111-113
         </a>
         ].
        </p>
        <p>
         Viral upper respiratory infections (URIs or colds) are the most frequent cause of asthma exacerbations. RV is the most frequent viral trigger for asthma exacerbations and may contribute to seasonal asthma morbidity. In adults and children, the presence of allergic sensitization is associated with a higher risk of wheezing and asthma exacerbations [
         <a href="#rid114">
          114
         </a>
         ] and worsening asthma control during RV-triggered asthma exacerbations compared with individuals with asthma but no allergies [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         One community study, for example, was conducted to identify the role of viral infections in asthma exacerbations in 9- to 11-year-old children [
         <a href="#rid109">
          109
         </a>
         ]. In this study, 108 children were followed for 13 months, during which episodes of wheezing were documented and nasal specimens obtained for culture and polymerase chain reaction (PCR) analysis for viruses. The following results were observed:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viruses were detected in over 80 percent of the episodes of reduced peak flow and wheezing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased symptoms of asthma usually occurred within 48 hours of developing a URI and persisted for at least two weeks.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The most commonly identified virus was RV (increasingly RV-C), accounting for approximately 60 percent of infections and wheezing episodes. RV-C was associated with more severe asthma exacerbations.
        </p>
        <p>
        </p>
        <p>
         In another study, one-third to one-half of weekly respiratory isolates obtained from six- to eight-year-old children with asthma contained detectable virus, with 72 to 99 percent of the viruses identified as RV [
         <a href="#rid11">
          11
         </a>
         ]. A subsequent weekly surveillance study during the H1N1 pandemic reported that samples from children with asthma were twice as likely to detect influenza as compared with children without asthma [
         <a href="#rid115">
          115
         </a>
         ].
        </p>
        <p>
         A more subjective study of 138 adult patients with asthma found that colds were reported during 80 percent (223 of 280) of episodes of wheezing, chest tightness, or breathlessness, and 89 percent (223 of 250) of colds were associated with asthma symptoms [
         <a href="#rid109">
          109
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Asthma hospitalizations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Viral infections, especially with RV, are the leading cause of increased rates of hospitalization for asthma that are consistently observed in late summer and early fall in many countries, including the United States, Canada, Mexico, and Israel [
         <a href="#rid116">
          116-118
         </a>
         ]. As an example, a Canadian study documented that asthma hospitalizations among school-aged children increased predictably after return to school following summer vacation and other breaks [
         <a href="#rid119">
          119
         </a>
         ]. Specifically, a September (or fall/autumnal) asthma epidemic is observed in this age group during the third week of the month, with lesser increases in asthma admissions two days later in preschool children and six days later in adults, consistent with transmission of viral infections  (
         <a class="graphic graphic_figure graphicRef60106" href="/z/d/graphic/60106.html" rel="external">
          figure 3
         </a>
         ).
        </p>
        <p>
         A similar peak in asthma hospitalization caused by RV infection is seen in the Southern Hemisphere in mid-February, which also coincides with their fall and the onset of the school year [
         <a href="#rid120">
          120
         </a>
         ]. A winter peak is primarily due to RSV, and a spring peak is caused by both RSV and RV. hMPV peaks in the winter season and extends through spring season [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         The association between
         <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">
          acetaminophen
         </a>
         use and the development of asthma is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/572.html" rel="external">
          "Risk factors for asthma", section on 'Acetaminophen'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viral respiratory infections, particularly with respiratory syncytial virus (RSV) and rhinovirus (RV), are the most common causes of wheezing in infants and young children, and they have important influences on the development of asthma  (
         <a class="graphic graphic_table graphicRef75402" href="/z/d/graphic/75402.html" rel="external">
          table 1
         </a>
         ). In addition, viral infections, most often with RV, are the most common causes of wheezing and asthma exacerbations in children and adults with pre-existing asthma. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         RSV is the most common cause of bronchiolitis and wheezing in children less than two years of age. Exposure to tobacco smoke and reduced lung function are risk factors associated with virus-induced wheezing in this age group. Respiratory viruses other than RSV are more common triggers in young children greater than two years of age. Human metapneumovirus (hMPV) is frequently associated with acute respiratory illnesses in infants and children younger than five years of age. Risk factors associated with recurrent virus-induced wheezing in this age group are associated with a predisposition to asthma, including allergic sensitization. (See
         <a class="local">
          'Role of viruses in wheezing in infants and young children'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Respiratory viruses interact with allergic sensitization and other microbes to promote recurrent virus-induced wheezing and the development of asthma via a number of mechanisms including increased recruitment of inflammatory cells, promotion of cytokine production, enhancement of allergic inflammation, and augmented airways hyperresponsiveness. (See
         <a class="local">
          'Role of viruses in asthma'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wheezing with viral respiratory infections, particularly with RSV and RV, are important predictors of the subsequent development of asthma. However, it is unclear whether certain viral respiratory infections play a role in asthma inception or if wheezing with these infections is a predictor of childhood asthma. (See
         <a class="local">
          'Development of asthma'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Viral respiratory infections are the most common cause of wheezing in children and adults with preexisting asthma. RV is the predominant pathogen and the most frequent trigger of virus-induced exacerbations in patients with preexisting asthma. Patients with asthma do not appear to be more susceptible to RV infection than healthy controls. However, they are at greater risk of developing more severe and prolonged lower respiratory tract symptoms with infection. (See
         <a class="local">
          'Asthma exacerbations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1204756366">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Sujani Kakumanu, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Carroll KN, Hartert TV. The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations. Immunol Allergy Clin North Am 2008; 28:539.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan WC. Viruses in asthma exacerbations. Curr Opin Pulm Med 2005; 11:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MacDowell AL, Bacharier LB. Infectious triggers of asthma. Immunol Allergy Clin North Am 2005; 25:45.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le Souëf PN. Gene-environmental interaction in the development of atopic asthma: new developments. Curr Opin Allergy Clin Immunol 2009; 9:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178:667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000; 161:1501.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigurs N, Gustafsson PM, Bjarnason R, et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 2005; 171:137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354:541.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kusel MM, de Klerk NH, Kebadze T, et al. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol 2007; 119:1105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holt PG, Sly PD. Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment. Nat Med 2012; 18:726.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olenec JP, Kim WK, Lee WM, et al. Weekly monitoring of children with asthma for infections and illness during common cold seasons. J Allergy Clin Immunol 2010; 125:1001.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coverstone AM, Wang L, Sumino K. Beyond Respiratory Syncytial Virus and Rhinovirus in the Pathogenesis and Exacerbation of Asthma: The Role of Metapneumovirus, Bocavirus and Influenza Virus. Immunol Allergy Clin North Am 2019; 39:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stark JM, Busse WW. Respiratory virus infection and airway hyperreactivity in children. Pediatr Allergy Immunol 1991; 2:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999; 282:1440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Bronchiolitis-associated outpatient visits and hospitalizations among American Indian and Alaska Native children--United States, 1990-2000. MMWR Morb Mortal Wkly Rep 2003; 52:707.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rakes GP, Arruda E, Ingram JM, et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses. Am J Respir Crit Care Med 1999; 159:785.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García-García ML, Calvo C, Casas I, et al. Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5. Pediatr Pulmonol 2007; 42:458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee WM, Kiesner C, Pappas T, et al. A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS One 2007; 2:e966.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García-García ML, Calvo C, Rey C, et al. Human metapnuemovirus infections in hospitalized children and comparison with other respiratory viruses. 2005-2014 prospective study. PLoS One 2017; 12:e0173504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards KM, Thompson J, Paolini J, Wright PF. Adenovirus infections in young children. Pediatrics 1985; 76:420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esper F, Weibel C, Ferguson D, et al. Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children. J Infect Dis 2005; 191:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foulongne V, Rodière M, Segondy M. Human Bocavirus in children. Emerg Infect Dis 2006; 12:862.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansbach JM, Camargo CA Jr. Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma. Clin Lab Med 2009; 29:741.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martinez FD, Morgan WJ, Wright AL, et al. Diminished lung function as a predisposing factor for wheezing respiratory illness in infants. N Engl J Med 1988; 319:1112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med 1995; 332:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gern JE, Rosenthal LA, Sorkness RL, Lemanske RF Jr. Effects of viral respiratory infections on lung development and childhood asthma. J Allergy Clin Immunol 2005; 115:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berry CE, Billheimer D, Jenkins IC, et al. A Distinct Low Lung Function Trajectory from Childhood to the Fourth Decade of Life. Am J Respir Crit Care Med 2016; 194:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stern DA, Morgan WJ, Wright AL, et al. Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study. Lancet 2007; 370:758.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Landau LI. Tobacco smoke exposure and tracking of lung function into adult life. Paediatr Respir Rev 2008; 9:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 2010; 125:1178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jartti T, Kuusipalo H, Vuorinen T, et al. Allergic sensitization is associated with rhinovirus-, but not other virus-, induced wheezing in children. Pediatr Allergy Immunol 2010; 21:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cox DW, Mullane D, Zhang GC, et al. Longitudinal assessment of airway responsiveness from 1 month to 18 years in the PIAF birth cohort. Eur Respir J 2015; 46:1654.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turner SW, Palmer LJ, Rye PJ, et al. The relationship between infant airway function, childhood airway responsiveness, and asthma. Am J Respir Crit Care Med 2004; 169:921.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jalink MB, Langley JM, Dodds L, Andreou P. Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma. Pediatr Infect Dis J 2019; 38:1121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bisgaard H, Hermansen MN, Bønnelykke K, et al. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ 2010; 341:c4978.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chong Neto HJ, Rosario N, Solé D, Mallol J. Associated factors for recurrent wheezing in infancy. Allergy 2010; 65:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pattemore PK, Johnston SL, Bardin PG. Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin Exp Allergy 1992; 22:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sterk PJ. Virus-induced airway hyperresponsiveness in man. Eur Respir J 1993; 6:894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duff AL, Pomeranz ES, Gelber LE, et al. Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 1993; 92:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemanske RF Jr, Jackson DJ, Gangnon RE, et al. Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol 2005; 116:571.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gern JE. Viral respiratory infection and the link to asthma. Pediatr Infect Dis J 2008; 27:S97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002; 359:831.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007; 204:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007; 179:1080.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson DJ, Makrinioti H, Rana BM, et al. IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med 2014; 190:1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beale J, Jayaraman A, Jackson DJ, et al. Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med 2014; 6:256ra134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards MR, Strong K, Cameron A, et al. Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness. J Allergy Clin Immunol 2017; 140:909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lynch SV, Wood RA, Boushey H, et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J Allergy Clin Immunol 2014; 134:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kloepfer KM, Lee WM, Pappas TE, et al. Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations. J Allergy Clin Immunol 2014; 133:1301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kloepfer KM, Sarsani VK, Poroyko V, et al. Community-acquired rhinovirus infection is associated with changes in the airway microbiome. J Allergy Clin Immunol 2017; 140:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson DJ. The role of rhinovirus infections in the development of early childhood asthma. Curr Opin Allergy Clin Immunol 2010; 10:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberg KA, Sullivan-Dillie KT, Evans MD, et al. Wheezing severe rhinovirus illnesses during infancy predict childhood asthma at age 6 years. J Allergy Clin Immunol 2007; 119:S157 (Abstract).
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kotaniemi-Syrjänen A, Vainionpää R, Reijonen TM, et al. Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma? J Allergy Clin Immunol 2003; 111:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sly PD, Kusel M, Holt PG. Do early-life viral infections cause asthma? J Allergy Clin Immunol 2010; 125:1202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carroll KN, Wu P, Gebretsadik T, et al. Season of infant bronchiolitis and estimates of subsequent risk and burden of early childhood asthma. J Allergy Clin Immunol 2009; 123:964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rantala AK, Jaakkola MS, Mäkikyrö EM, et al. Early Respiratory Infections and the Development of Asthma in the First 27 Years of Life. Am J Epidemiol 2015; 182:615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenthal LA, Avila PC, Heymann PW, et al. Viral respiratory tract infections and asthma: the course ahead. J Allergy Clin Immunol 2010; 125:1212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu P, Dupont WD, Griffin MR, et al. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med 2008; 178:1123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bartlett NW, McLean GR, Chang YS, Johnston SL. Genetics and epidemiology: asthma and infection. Curr Opin Allergy Clin Immunol 2009; 9:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Becker S, Quay J, Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J Immunol 1991; 147:4307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Becker S, Koren HS, Henke DC. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6. Am J Respir Cell Mol Biol 1993; 8:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Einarsson O, Panusak J, Zhu Z, et al. Respiratory syncytial virus stimulation of interleukin-11 production by airway epithelial cells and lung fibroblasts. Am J Respir Crit Care Med 1994; 149:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noah TL, Becker S. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line. Am J Physiol 1993; 265:L472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garofalo R, Mei F, Espejo R, et al. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J Immunol 1996; 157:2506.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson SM, McNally BA, Ioannidis I, et al. Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures. PLoS Pathog 2015; 11:e1005318.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guo-Parke H, Canning P, Douglas I, et al. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium. Am J Respir Crit Care Med 2013; 188:842.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gern JE. Rhinovirus and the initiation of asthma. Curr Opin Allergy Clin Immunol 2009; 9:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigurs N, Aljassim F, Kjellman B, et al. Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life. Thorax 2010; 65:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Simões EA, Carbonell-Estrany X, Rieger CH, et al. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol 2010; 126:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaheen SO. Changing patterns of childhood infection and the rise in allergic disease. Clin Exp Allergy 1995; 25:1034.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cypcar D, Busse WW. Role of viral infections in asthma. Immunol Allergy Clin North Am 1993; 13:745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigurs N, Bjarnason R, Sigurbergsson F, et al. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. Pediatrics 1995; 95:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cogswell JJ, Halliday DF, Alexander JR. Respiratory infections in the first year of life in children at risk of developing atopy. Br Med J (Clin Res Ed) 1982; 284:1011.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Welliver RC. RSV and chronic asthma. Lancet 1995; 346:789.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bacharier LB, Cohen R, Schweiger T, et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol 2012; 130:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013; 368:1791.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scheltema NM, Nibbelke EE, Pouw J, et al. Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial. Lancet Respir Med 2018; 6:257.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bochkov YA, Watters K, Ashraf S, et al. Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication. Proc Natl Acad Sci U S A 2015; 112:5485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gern JE, Vrtis R, Grindle KA, et al. Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection. Am J Respir Crit Care Med 2000; 162:2226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holt PG, Strickland DH, Hales BJ, Sly PD. Defective respiratory tract immune surveillance in asthma: a primary causal factor in disease onset and progression. Chest 2014; 145:370.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Durrani SR, Montville DJ, Pratt AS, et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol 2012; 130:489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gill MA, Bajwa G, George TA, et al. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol 2010; 184:5999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wark PA, Johnston SL, Bucchieri F, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005; 201:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Contoli M, Ito K, Padovani A, et al. Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells. Allergy 2015; 70:910.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Savenije OE, Mahachie John JM, Granell R, et al. Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol 2014; 134:170.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grayson MH, Cheung D, Rohlfing MM, et al. Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia. J Exp Med 2007; 204:2759.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pyle DM, Yang VS, Gruchalla RS, et al. IgE cross-linking critically impairs human monocyte function by blocking phagocytosis. J Allergy Clin Immunol 2013; 131:491.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esquivel A, Busse WW, Calatroni A, et al. Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma. Am J Respir Crit Care Med 2017; 196:985.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol 2015; 136:1476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calışkan M, Bochkov YA, Kreiner-Møller E, et al. Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013; 368:1398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bønnelykke K, Sleiman P, Nielsen K, et al. A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet 2014; 46:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Edwards KM, Zhu Y, Griffin MR, et al. Burden of human metapneumovirus infection in young children. N Engl J Med 2013; 368:633.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coverstone AM, Wilson B, Burgdorf D, et al. Recurrent wheezing in children following human metapneumovirus infection. J Allergy Clin Immunol 2018; 142:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dawood FS, Kamimoto L, D'Mello TA, et al. Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009. Pediatrics 2011; 128:e27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Merckx J, Ducharme FM, Martineau C, et al. Respiratory Viruses and Treatment Failure in Children With Asthma Exacerbation. Pediatrics 2018; 142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol 2020; 146:110.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang JJ, Dong X, Cao YY, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020; 75:1730.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skevaki C, Karsonova A, Karaulov A, et al. Asthma-associated risk for COVID-19 development. J Allergy Clin Immunol 2020; 146:1295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chhiba KD, Patel GB, Vu THT, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol 2020; 146:307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grandbastien M, Piotin A, Godet J, et al. SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation. J Allergy Clin Immunol Pract 2020; 8:2600.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahdavinia M, Foster KJ, Jauregui E, et al. Asthma prolongs intubation in COVID-19. J Allergy Clin Immunol Pract 2020; 8:2388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol 2020; 146:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kimura H, Francisco D, Conway M, et al. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol 2020; 146:80.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bradding P, Richardson M, Hinks TSC, et al. ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19. J Allergy Clin Immunol 2020; 146:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bardin PG, Johnston SL, Pattemore PK. Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms. Clin Exp Allergy 1992; 22:809.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan WC, Xiang X, Qiu D, et al. Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease. Am J Med 2003; 115:272.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnston SL, Bardin PG, Pattemore PK. Viruses as precipitants of asthma symptoms. III. Rhinoviruses: molecular biology and prospects for future intervention. Clin Exp Allergy 1993; 23:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993; 307:982.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bizzintino J, Lee WM, Laing IA, et al. Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J 2011; 37:1037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mak RK, Tse LY, Lam WY, et al. Clinical spectrum of human rhinovirus infections in hospitalized Hong Kong children. Pediatr Infect Dis J 2011; 30:749.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iwane MK, Prill MM, Lu X, et al. Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children. J Infect Dis 2011; 204:1702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Green RM, Custovic A, Sanderson G, et al. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002; 324:763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kloepfer KM, Olenec JP, Lee WM, et al. Increased H1N1 infection rate in children with asthma. Am J Respir Crit Care Med 2012; 185:1275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bates DV, Baker-Anderson M, Sizto R. Asthma attack periodicity: a study of hospital emergency visits in Vancouver. Environ Res 1990; 51:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weiss KB. Seasonal trends in US asthma hospitalizations and mortality. JAMA 1990; 263:2323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kimes D, Levine E, Timmins S, et al. Temporal dynamics of emergency department and hospital admissions of pediatric asthmatics. Environ Res 2004; 94:7.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnston NW, Johnston SL, Norman GR, et al. The September epidemic of asthma hospitalization: school children as disease vectors. J Allergy Clin Immunol 2006; 117:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maffey AF, Barrero PR, Venialgo C, et al. Viruses and atypical bacteria associated with asthma exacerbations in hospitalized children. Pediatr Pulmonol 2010; 45:619.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 535 Version 30.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18572106" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15591884" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Viruses in asthma exacerbations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15579364" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Infectious triggers of asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19295429" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Gene-environmental interaction in the development of atopic asthma: new developments.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18565953" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10806145" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15516534" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10470697" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17353039" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22561836" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Viral infections and atopy in asthma pathogenesis: new rationales for asthma prevention and treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20392488" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Weekly monitoring of children with asthma for infections and illness during common cold seasons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31284928" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Beyond Respiratory Syncytial Virus and Rhinovirus in the Pathogenesis and Exacerbation of Asthma: The Role of Metapneumovirus, Bocavirus and Influenza Virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Respiratory virus infection and airway hyperreactivity in children
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10535434" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Bronchiolitis-associated hospitalizations among US children, 1980-1996.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12894058" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Bronchiolitis-associated outpatient visits and hospitalizations among American Indian and Alaska Native children--United States, 1990-2000.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10051251" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care. IgE and eosinophil analyses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17427899" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17912345" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28301570" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Human metapnuemovirus infections in hospitalized children and comparison with other respiratory viruses. 2005-2014 prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2993992" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Adenovirus infections in young children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15655770" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Evidence of a novel human coronavirus that is associated with respiratory tract disease in infants and young children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16710957" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Human Bocavirus in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19892232" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3173442" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Diminished lung function as a predisposing factor for wheezing respiratory illness in infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7800004" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Asthma and wheezing in the first six years of life. The Group Health Medical Associates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15805982" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Effects of viral respiratory infections on lung development and childhood asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27585385" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : A Distinct Low Lung Function Trajectory from Childhood to the Fourth Decade of Life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17765525" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Poor airway function in early infancy and lung function by age 22 years: a non-selective longitudinal cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18280978" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Tobacco smoke exposure and tracking of lung function into adult life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20513517" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : The role of viruses in acute exacerbations of asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20977499" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Allergic sensitization is associated with rhinovirus-, but not other virus-, induced wheezing in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26493795" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Longitudinal assessment of airway responsiveness from 1 month to 18 years in the PIAF birth cohort.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14764431" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : The relationship between infant airway function, childhood airway responsiveness, and asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31425330" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Severe Respiratory Syncytial Virus Infection in Preterm Infants and Later Onset of Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20921080" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19796216" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Associated factors for recurrent wheezing in infancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1586873" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Viruses as precipitants of asthma symptoms. I. Epidemiology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8393410" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Virus-induced airway hyperresponsiveness in man.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8414823" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16159626" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Rhinovirus illnesses during infancy predict subsequent childhood wheezing.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18820588" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Viral respiratory infection and the link to asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11897281" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17242164" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17617600" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25350863" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25273095" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28987220" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Viral infections in allergy and immunology: How allergic inflammation influences viral infections and illness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24908147" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24698319" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28327377" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Community-acquired rhinovirus infection is associated with changes in the airway microbiome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19996738" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The role of rhinovirus infections in the development of early childhood asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Wheezing severe rhinovirus illnesses during infancy predict childhood asthma at age 6 years
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12532098" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Rhinovirus-induced wheezing in infancy--the first sign of childhood asthma?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20304476" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Do early-life viral infections cause asthma?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19181372" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Season of infant bronchiolitis and estimates of subsequent risk and burden of early childhood asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26362307" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Early Respiratory Infections and the Development of Asthma in the First 27 Years of Life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20513518" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Viral respiratory tract infections and asthma: the course ahead.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18776151" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Evidence of a causal role of winter virus infection during infancy in early childhood asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19644362" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Genetics and epidemiology: asthma and infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1753101" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8417753" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Respiratory syncytial virus stimulation of interleukin-11 production by airway epithelial cells and lung fibroblasts
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8238534" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8805651" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26658574" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23952745" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19532096" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Rhinovirus and the initiation of asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20581410" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20624638" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8581834" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Changing patterns of childhood infection and the rise in allergic disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Role of viral infections in asthma
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7700748" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6802386" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Respiratory infections in the first year of life in children at risk of developing atopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7674741" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : RSV and chronic asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22444510" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Determinants of asthma after severe respiratory syncytial virus bronchiolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23656644" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Respiratory syncytial virus and recurrent wheeze in healthy preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29500030" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25848009" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11112143" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Relationship of upper and lower airway cytokines to outcome of experimental rhinovirus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24493508" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Defective respiratory tract immune surveillance in asthma: a primary causal factor in disease onset and progression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22766097" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20410486" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15781584" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25858686" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24568840" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17954569" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Induction of high-affinity IgE receptor on lung dendritic cells during viral infection leads to mucous cell metaplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23374271" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : IgE cross-linking critically impairs human monocyte function by blocking phagocytosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28608756" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26518090" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23534543" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Rhinovirus wheezing illness and genetic risk of childhood-onset asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24241537" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23406028" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Burden of human metapneumovirus infection in young children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29481834" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Recurrent wheezing in children following human metapneumovirus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21646257" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Children with asthma hospitalized with seasonal or pandemic influenza, 2003-2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29866794" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Respiratory Viruses and Treatment Failure in Children With Asthma Exacerbation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32173574" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32294485" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32077115" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33002516" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Asthma-associated risk for COVID-19 development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32554082" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32603901" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : SARS-CoV-2 Pneumonia in Hospitalized Asthmatic Patients Did Not Induce Severe Exacerbation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32417445" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Asthma prolongs intubation in COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32333915" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32422146" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32450087" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : ACE2, TMPRSS2, and furin gene expression in the airways of people with asthma-implications for COVID-19.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1358415" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Viruses as precipitants of asthma symptoms. II. Physiology and mechanisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12967691" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Epidemiology of respiratory viruses in patients hospitalized with near-fatal asthma, acute exacerbations of asthma, or chronic obstructive pulmonary disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8100475" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Viruses as precipitants of asthma symptoms. III. Rhinoviruses: molecular biology and prospects for future intervention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7767192" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Community study of role of viral infections in exacerbations of asthma in 9-11 year old children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8241910" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Respiratory viruses and exacerbations of asthma in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20693244" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Association between human rhinovirus C and severity of acute asthma in children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21494174" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Clinical spectrum of human rhinovirus infections in hospitalized Hong Kong children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22013207" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Human rhinovirus species associated with hospitalizations for acute respiratory illness in young US children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11923159" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22366048" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Increased H1N1 infection rate in children with asthma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2298182" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Asthma attack periodicity: a study of hospital emergency visits in Vancouver.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2325233" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Seasonal trends in US asthma hospitalizations and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14643281" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Temporal dynamics of emergency department and hospital admissions of pediatric asthmatics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16522453" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : The September epidemic of asthma hospitalization: school children as disease vectors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20503289" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Viruses and atypical bacteria associated with asthma exacerbations in hospitalized children.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
